Novartis India Ltd. (NOVARTIND): Novartis India Share Price hits fresh 52-week high on 10 September 2026
- September 10, 2026
- Posted by: Harsh Piplani
- Category: News
Novartis India Share Price stood at Rs 2,380.90, up 8.82% today, after touching a fresh 52-week high of Rs 2,383. The company’s market capitalisation was Rs 5,402.35 crore.
Novartis India Share Price opened the morning trading session with a sharp move to Rs 2,380.90, up Rs 192.90 from the previous close of Rs 2,188. The stock touched a fresh 52-week high of Rs 2,383, keeping Novartis India Ltd. (NOVARTIND) in focus in Novartis India Stock News and Novartis India Share Price Today searches. With a market capitalisation of Rs 5,402.35 crore, the move stands out as an event-led price update rather than a broad market story. According to latest Univest data, the stock event confirms a one-year high, while the data does not establish a company-specific catalyst. For readers following Novartis India Share Price Live, the key facts today are the price jump, the new yearly high and the valuation context around the move.
Novartis India Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 2,380.9 |
| Previous Close | Rs 2,188 |
| Today's Move | +Rs 192.9 (+8.82%) |
| Open | Rs 2,252 |
| High | Rs 2,383 |
| Low | Rs 2,238.35 |
| Turnover | Rs 5.37 crore |
| Market Capitalisation | Rs 5,402.35 crore |
Novartis India Ltd. (NOVARTIND) traded at Rs 2,380.9 versus the previous close of Rs 2,188, a rise of 8.82%. The stock opened at Rs 2,252, reached a high of Rs 2,383 and touched a low of Rs 2,238.35.
Novartis India Share Price traded at Rs 2,380.90 after opening at Rs 2,252 and moving between Rs 2,238.35 and Rs 2,383 during the session. The day change of Rs 192.90 translated into an 8.82% rise versus the previous close of Rs 2,188. The turnover stood at Rs 5.37 crore, which is the factual traded-value metric available for the move. The fresh 52-week high of Rs 2,383 means the stock also set a new one-year high in the same trading window. That makes the price action central to Novartis India Share Price Today, Novartis India Share News and Novartis India Stock News searches, even without assigning a cause beyond the verified price event.
Novartis India Ltd. (NOVARTIND) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 5,402.35 crore |
| P/E Ratio | 55.26x |
| P/B Ratio | 6.36x |
| ROE | 13.19% |
| ROCE | 17.15% |
| EPS | Rs 39.6 |
| Book Value Per Share | Rs 344.28 |
| Dividend Yield | 0% |
Novartis India Ltd. (NOVARTIND) fundamental metrics show P/E 55.26x, P/B 6.36x, ROE 13.19%, ROCE 17.15%. These figures provide context only and are not a buy or sell signal.
Novartis India Ltd. has a market capitalisation of Rs 5402.35 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 55.26x, P/B at 6.36x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 13.19% and ROCE of 17.15%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 39.6, book value per share of Rs 344.28, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 23.84x, median ROE of 4.1%, median ROCE of 6.09%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Trading |
| Industry | Trading |
| Benchmark Scope | same industry |
| Company P/E Ratio | 55.26x |
| Benchmark Median P/E | 23.84x |
| Benchmark Average P/E | 111.86x |
| Benchmark P/E Range | 0.12x to 8,413.86x |
| Company P/B Ratio | 6.36x |
| Benchmark Median P/B | 1.42x |
| Company ROE | 13.19% |
| Benchmark Median ROE | 4.1% |
| Company ROCE | 17.15% |
| Benchmark Median ROCE | 6.09% |
| Company Market Capitalisation | Rs 5,402.35 crore |
| Benchmark Median Market Cap | Rs 53.5 crore |
Novartis India Ltd. (NOVARTIND) is classified under sector: Trading and industry: Trading.
Novartis India Ltd. (NOVARTIND) has a P/E ratio of 55.26x, which is above the benchmark median of 23.84x, a difference of +131.8%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Novartis India Ltd. (NOVARTIND) has a ROE of 13.19%, which is above the benchmark median of 4.1%, a difference of +221.71%. Novartis India Ltd. (NOVARTIND) has a ROCE of 17.15%, which is above the benchmark median of 6.09%, a difference of +181.61%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Rashi Peripherals Ltd. | RPTECH | 5,434.31 | 16.56 | 2.51 | 15.07 | 17.18 |
| Optiemus Infracom Ltd. | OPTIEMUS | 5,016.86 | 67.3 | 5.45 | 12.53 | 16.05 |
| PDS Ltd. | PDSL | 4,893.12 | 41.61 | 2.78 | 10.72 | 13.49 |
| Jeena Sikho Lifecare Ltd. | JSLL | 6,283.4 | 26.59 | 11.86 | 61.61 | 84.75 |
| GNG Electronics Ltd. | EBGNG | 7,566.37 | 54.07 | 9.79 | 26.83 | 20.58 |
Novartis India Ltd. (NOVARTIND) has a P/E ratio of 55.26x compared with the displayed peer median of 41.61x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 13.19% compares with a peer median of 15.07% across the companies shown in the table. ROCE stood at 17.15% versus the displayed peer median of 17.18%, providing a capital-efficiency comparison. Novartis India Ltd. (NOVARTIND) has a market capitalisation of Rs 5,402.35 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching Novartis India
- Novartis India Share Price touched Rs 2,383, which is the fresh 52-week high and the one-year high recorded in this trading window.
- The stock traded at Rs 2,380.90, up 8.82% from the previous close of Rs 2,188.
- Market capitalisation stood at Rs 5,402.35 crore, placing the company above the sector median market cap in the benchmark set.
- P/E is 55.26, P/B is 6.36, ROE is 13.19% and ROCE is 17.15%, giving clear valuation and profitability context.
- Recent revenue for Jun 26 was Rs 1,038.1 crore, while recent net profit for Jun 26 was Rs 322.1 crore.
About Novartis India
Novartis India Ltd. is classified in the Trading sector and Trading industry. For readers following Novartis India Share Price and Novartis India Company News, the key profile markers in today’s update are the company’s market-cap size, valuation multiples and profitability ratios. Novartis India Share Price therefore sits within a trading-industry context that can be tracked through Novartis India Share Price Update, Novartis India Latest News and Novartis India Stock Performance coverage on Univest.
Frequently Asked Questions
Why did Novartis India Share Price hit a fresh 52-week high?
Ans. Novartis India Share Price touched Rs 2,383, its fresh 52-week high, while trading at Rs 2,380.90. The verified data confirms the price event but does not establish a company-specific catalyst.
What is Novartis India Share Price today?
Ans. Novartis India Share Price was Rs 2,380.90, up Rs 192.90 or 8.82% from the previous close of Rs 2,188. The stock also marked a fresh yearly high during the same session.
What was the previous close for Novartis India Share Price?
Ans. The previous close for Novartis India Share Price was Rs 2,188. The current trading level of Rs 2,380.90 shows a clear intraday gain versus that reference point. The stock moved 8.82% so far today.
What is the market capitalisation of Novartis India?
Ans. Novartis India has a market capitalisation of Rs 5,402.35 crore. That places it above the sector median market cap in the same-industry benchmark set of 459 companies. The company operates in the Trading sector.
How is Novartis India valued on earnings and book value?
Ans. Novartis India Share Price is linked to a P/E of 55.26 and a P/B of 6.36. EPS is Rs 39.6 and book value per share is Rs 344.28, offering a clear valuation frame.
What do ROE and ROCE show for Novartis India?
Ans. ROE is 13.19% and ROCE is 17.15% for Novartis India. Both are above the sector medians of 4.1% and 6.09% respectively in the same-industry benchmark set.
Does Novartis India pay a dividend?
Ans. The dividend yield reported for Novartis India is 0. That means the current share-price update carries no dividend-yield figure in the latest financial snapshot.
How does Novartis India compare with peers?
Ans. Novartis India Share Price sits above Rashi Peripherals and PDS on valuation multiples, while its ROCE of 17.15% matches Rashi Peripherals. The peer set gives a useful relative market-cap and valuation view.
Track Novartis India Share Price on Univest
Use Novartis India Ltd. (NOVARTIND) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track Novartis India Share Price on Univest for live share price updates, market cap, financial ratios, 52-week levels, peer context, revenue trends and market insights. Univest also helps readers follow Novartis India Share Price Today, Novartis India Share Price Live and Novartis India Stock News in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
